Comprehensive Characterization of Cancer Subtype Associated Long Non-coding RNAs and Their Clinical Implications

Overview

Journal Sci Rep

Specialty Science

Date 2014 Oct 14

PMID 25307233

Citations 68

Authors

Weihong Zhao

Jiancheng Luo

Shunchang Jiao

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) are a kind of RNAs with regulation that participate fundamental cellular processes via diverse mechanisms. Despite the potential importance of lncRNAs in multiple kinds of cancer has been well studied, no comprehensive survey of cancer subtype associated lncRNAs. Here, we performed an array-based transcriptional survey of lncRNAs across 150 lung cancer samples comprising both adenocarcinoma and squamous cell carcinoma, and 306 breast cancer patients with clear clinical information. In lung cancer, 72 lncRNAs are identified to be associated with tumor subtypes and their functions as well as the associated proteins are predicted by constructing coding-non-coding co-expression network. The results suggest that they are mostly related with epidermis development, cell adhesion and response to stimulus. The validation results show the high concordance and confirmed the robust of the identification results. In breast cancer, we found 3 lncRNA genes are associated with estrogen receptor α (ER) positive and ER negative subtypes and tumor histologic grade. Survival (Kaplan-Meier) analysis results suggest that the expression pattern of the 3 lncRNAs is significantly correlated with clinical outcomes. The current study provides the first large-scale survey of lncRNAs within cancer subtypes, and may offer new targets for their diagnosis, therapy and prognosis.

Citing Articles

LncRNA PTPRG-AS1 Promotes Breast Cancer Progression by Modulating the miR-4659a-3p/QPCT Axis.

Zhou M, Li Y, Yang L, Liu S, Yang L, Xu B Onco Targets Ther. 2024; 17:805-819.

PMID: 39380914 PMC: 11460282. DOI: 10.2147/OTT.S474898.

As a novel prognostic model for breast cancer, the identification and validation of telomere-related long noncoding RNA signatures.

Zhao W, Li B, Zhang M, Zhou P, Zhu Y World J Surg Oncol. 2024; 22(1):245.

PMID: 39261898 PMC: 11389561. DOI: 10.1186/s12957-024-03514-2.

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma.

Davis W, Drummond C, Diermeier S, Reid G Genes (Basel). 2024; 15(7).

PMID: 39062685 PMC: 11276205. DOI: 10.3390/genes15070906.

Non-coding RNA's prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer.

Ali R, Laskar S, Khan N, Wahab S, Khalid M Funct Integr Genomics. 2023; 23(2):195.

PMID: 37270446 DOI: 10.1007/s10142-023-01123-y.

SADLN: Self-attention based deep learning network of integrating multi-omics data for cancer subtype recognition.

Sun Q, Cheng L, Meng A, Ge S, Chen J, Zhang L Front Genet. 2023; 13:1032768.

PMID: 36685873 PMC: 9846505. DOI: 10.3389/fgene.2022.1032768.

References

Bakir K, Kocer N, Deniz H, Guldur M . TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma. Ann Diagn Pathol. 2004; 8(6):337-41. DOI: 10.1053/j.anndiagpath.2004.08.003. View

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100(14):8418-23. PMC: 166244. DOI: 10.1073/pnas.0932692100. View

Chen L, Redon S, Lingner J . The human CST complex is a terminator of telomerase activity. Nature. 2012; 488(7412):540-4. DOI: 10.1038/nature11269. View

Gomez-Fernandez C, Jorda M, Delgado P, Ganjei-Azar P . Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids. Cancer. 2002; 96(5):289-93. DOI: 10.1002/cncr.10743. View

Liao Q, Liu C, Yuan X, Kang S, Miao R, Xiao H . Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011; 39(9):3864-78. PMC: 3089475. DOI: 10.1093/nar/gkq1348. View

Merico D, Isserlin R, Stueker O, Emili A, Bader G . Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 2010; 5(11):e13984. PMC: 2981572. DOI: 10.1371/journal.pone.0013984. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Gruvberger S, Ringner M, Chen Y, Panavally S, Saal L, Borg A . Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001; 61(16):5979-84. View

10.

Liao Q, Xiao H, Bu D, Xie C, Miao R, Luo H . ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res. 2011; 39(Web Server issue):W118-24. PMC: 3125796. DOI: 10.1093/nar/gkr432. View

11.

Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19):10869-74. PMC: 58566. DOI: 10.1073/pnas.191367098. View

12.

Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu E . Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer. 2008; 63(1):32-8. DOI: 10.1016/j.lungcan.2008.03.033. View

13.

Yildiz O, Buyuktas D, Ekiz E, Selcukbiricik F, Papila I, Papila C . Facial nerve palsy: an unusual presenting feature of small cell lung cancer. Case Rep Oncol. 2011; 4(1):35-8. PMC: 3082487. DOI: 10.1159/000324182. View

14.

Sun S, Schiller J, Gazdar A . Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007; 7(10):778-90. DOI: 10.1038/nrc2190. View

15.

Liu S, Sugimoto Y, Sorio C, Tecchio C, Lin Y . Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene. 2003; 23(6):1256-62. DOI: 10.1038/sj.onc.1207235. View

16.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

17.

Zheng J, Kulp S, Zhang Y, Sugimoto Y, Dayton M, Govindan M . 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Anticancer Res. 2000; 20(1A):11-9. View

18.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

19.

Perner S, Wagner P, Soltermann A, Lafargue C, Tischler V, Weir B . TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol. 2008; 217(1):65-72. DOI: 10.1002/path.2443. View

20.

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H . The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22(9):1775-89. PMC: 3431493. DOI: 10.1101/gr.132159.111. View